Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
Background: The goal of the present cohort study was to review outcomes of patients exposed to interferon beta-1b during pregnancy. Methods: Pregnancy cases with exposure to interferon beta-1b reported to Bayer’s pharmacovigilance (PV) database from worldwide sources from January 1995 through Februa...
Main Authors: | Kerstin Hellwig, Fernando Duarte Caron, Eva-Maria Wicklein, Aasia Bhatti, Alessandra Adamo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-03-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286420910310 |
Similar Items
-
Detecting medication errors associated with the use of beta-lactams in the Russian Pharmacovigilance database
by: Anna V. Kuzmina, et al.
Published: (2021-01-01) -
Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
by: Alessandro Ceschi, et al.
Published: (2020-05-01) -
The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
by: Sarah Burkill, et al.
Published: (2019-01-01) -
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
by: Kerstin Hellwig, et al.
Published: (2012-09-01) -
Pharmacoepidemiology and pharmacovigilance in pregnancy: experience of the regional service of clinical pharmacology
by: E V Eliseeva, et al.
Published: (2013-08-01)